Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may be less effective in women who are obese.
Obesity raises odds for recurrence in breast cancer survivors, finds study medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
BriaCell Therapeutics (BCTX) Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Median overall survival of 13.5 months in BriaCell’s advanced metastatic breast cancer patients (vs. 6.7-9.8 months for similar patients reported in the.
/PRNewswire/ STAT, the leading media company reporting on health, science, and medicine, is proud to host its inaugural STAT Future Summit next week, Sept..